Science Wins Swiss Animal Test Ban Vote

Science Wins Swiss Animal Test Ban Vote

While discussions about animal testing tend to revolve around ethical questions, they often overlook an important – and, arguably, THE MOST IMPORTANT issue: Animal testing does not reliably predict how products will affect people. For example, science has cured a number of brain disorders in mice, but has yet to do it in people.

Read More

Despite US Law, Fewer Than Half of US Clinical Trials Report Results by the Required Deadline

Despite US Law, Fewer Than Half of US Clinical Trials Report Results by the Required Deadline

Patients, researchers, pharmaceutical companies, clinicians, amongst others, all rely on the release of clinical trial results. Despite this, a report published by The Lancet indicated that only 41% of completed clinical trials reported results within the deadline. In the meantime, a team at Oxford are doing their part, using AI and Machine Learning to spot unreported trials, advocating on behalf of all those who could benefit from proper reporting, and encouraging sponsors to report. Learn more about this problem below.

Read More

What's New in the World of Alzheimers Research?

What's New in the World of Alzheimers Research?

Despite the vast population Alzheimer’s disease affects each year, no new drugs have been approved by the FDA in 16 years. The lack of success in AD drug development has infused scepticism in the field. This recent scientific publication shows the latest developments in the AD drug pipeline as of 2019.

Read More